Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

BACKGROUND: High probability of metastasis limited the long-term survival of patients with hepatocellular carcinoma (HCC). Our previous study revealed that Galectin-3 was closely associated with poor prognosis in HCC patients. METHODS: The effects of Galectin-3 on tumour metastasis were investigated...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Br J Cancer
Κύριοι συγγραφείς: Song, Mengjia, Pan, Qiuzhong, Yang, Jieying, He, Junyi, Zeng, Jianxiong, Cheng, Shaoyan, Huang, Yue, Zhou, Zi-Qi, Zhu, Qian, Yang, Chaopin, Han, Yulong, Tang, Yan, Chen, Hao, Weng, De-Sheng, Xia, Jian-Chuan
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Nature Publishing Group UK 2020
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7653936/
https://ncbi.nlm.nih.gov/pubmed/32801345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-1022-4
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια